Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?

Dosimetrically, gated MRgRT was beneficial for virtually all the hepatic metastases analyzed in this study. Patients with metastases located critically near gastrointestinal OAR or with limited healthy liver volume should be allocated to centers providing MRgRT.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2025-02-28
DOI
https://doi.org/10.1016/j.ctro.2025.100941
Citations
2
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
3.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?

Oliver Sedlaczek, Heinz‐Peter Schlemmer, C. Katharina Renkamp, Sebastian Regnery et al.
2 citations
Clinical and Translational Radiation Oncology
Advanced Radiotherapy Techniques
3.77
article

Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?

Oliver Sedlaczek, Heinz‐Peter Schlemmer, C. Katharina Renkamp, Sebastian Regnery, Jakob Liermann, Harold Lau, Carolin Buchele, Eva Meixner, Line Hoeltgen, Fabian Schlüter, Laila König, Kevin S. Zhang, Sebastian Klüter, Elisabetta Sandrini, Nina I. Niebuhr, Juliane Hörner‐Rieber, Jürgen Debus, Fabian Weykamp, Philipp Hoegen-Saßmannshausen, David Neugebauer
article en
2 citations

Abstract

Dosimetrically, gated MRgRT was beneficial for virtually all the hepatic metastases analyzed in this study. Patients with metastases located critically near gastrointestinal OAR or with limited healthy liver volume should be allocated to centers providing MRgRT.

Clinical and Translational Radiation OncologyVol. 52
German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), Düsseldorf University Hospital (DE), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE), Klinikum Ludwigsburg (DE), Deutsches Konsortium für Translationale Krebsforschung (DE), Heinrich Heine University Düsseldorf (DE)
Pfizer, AstraZeneca, Sanofi, Varian Medical Systems, Novocure, Accuray, ViewRay, Deutsche Forschungsgemeinschaft, Dietmar Hopp Stiftung
Openalex Percentile: Top 9%
Advanced Radiotherapy Techniques
3.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.